Retrospective, Non-interventional Natural History of Patients With Juvenile-onset Hypophosphatasia (HPP)
Study Identifier:
ALX-HPP-502
ClinicalTrials.gov Identifier:
EudraCT Identifier:
N/A
Sponsor:
Alexion Pharmaceuticals, Inc.
Study Contact Information:
N/A
Study Complete
Study Details
Medical Condition
- Unmapped
Study Drug
Date
Mar 2014 - Sep 2014
Phase 1
Phase 2
Phase 3
Phase 4
N/A
Patient Requirements
Sex: Female & Male
Age: 5+ years
Requirements Information
Sex
Female & Male
Age
5+ years
Study Details
Medical Condition
- Unmapped
Study Drug
Date
Mar 2014 - Sep 2014
Phase 1
Phase 2
Phase 3
Phase 4
N/A
Patient Requirements
Sex: Female & Male
Age: 5+ years years
Requirements Information
Protocol Summary
The purpose of this study is to characterize the natural history of HPP in patients with Juvenile-onset HPP.
Trial Locations
Location
Status
Location
Atlanta, Georgia, United States
Status
N/A
Location
Indianapolis, Indiana, United States
Status
N/A
Location
Boston, Massachusetts, United States
Status
N/A
Location
Saint Louis, Missouri, United States
Status
N/A
Location
Springfield, Missouri, United States
Status
N/A
Location
Durham, North Carolina, United States
Status
N/A